Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce (CELG-RI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CELG-RI · as of Sep 30, 2025
Ownership Breakdown
21
Institutional Holders
▲ 1 vs Q2
$40,486
Total Inst. Value
▲ $27,909 vs Q2
2.04B
Shares Outstanding
freeFloat 99.68%
1.22M
13F Shares Held
▲ 716,392 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CELG-RI largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TORONTO DOMINION BANK pharmaceutical preparations | 807.8K | 3.98% | 3.98% | $1.21B | Nov 14, 2025 | NEW |
TRANSCEND CAPITAL ADVISORS, LLC pharmaceutical preparations | 109.2K | 0.54% | 0.54% | $3.23M | Nov 4, 2025 | — held |
DAVENPORT & CO LLC pharmaceutical preparations | 84.0K | 0.41% | 0.41% | $2.79M | Oct 15, 2025 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 51.8K | 0.26% | 0.26% | $1.50M | Feb 3, 2026 | — held |
CITADEL ADVISORS LLC pharmaceutical preparations | 32.8K | 0.16% | 0.16% | $1.09M | Nov 14, 2025 | ▼ 2.6K |
PURKISS CAPITAL ADVISORS LLC pharmaceutical preparations | 26.4K | 0.13% | 0.13% | $783,000 | Oct 31, 2025 | — held |
SUSQUEHANNA INTERNATIONAL GROUP, LLP pharmaceutical preparations | 25.1K | 0.12% | 0.12% | $834,000 | Nov 14, 2025 | ▼ 12.0K |
WATTS GWILLIAM & CO., LLC pharmaceutical preparations | 20.0K | 0.10% | 0.10% | $592,000 | Nov 21, 2025 | — held |
FIFTH THIRD BANCORP pharmaceutical preparations | 20.0K | 0.10% | 0.10% | $592,000 | Nov 7, 2025 | — held |
PRIVATE ADVISOR GROUP, LLC pharmaceutical preparations | 15.0K | 0.07% | 0.07% | $444,000 | Nov 13, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+290 shares2
New Positions
first time holders3
Decreased
−23.9K shares2
Sold Out
fully exitedNet shares change (top 50)
23.6K
+290 / −23.9K
Net new holders
-1
2 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CELG-RI insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 24,209 | — | — | 60.9K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 13,906 | — | — | 36.7K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | Award | 8,634 | — | — | 22.8K | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 18,257 | $88.91 | $1.62M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 18,257 | $71.43 | $1.30M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 613 | — | — | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 26,308 | $100.97 | $2.66M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 3,125 | $114.08 | $356.5K | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 12,906 | $113.18 | $1.46M | 0 | Form 4 ↗ |
VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | Nov 20, 2019 | D-Return | 11,384 | $124.06 | $1.41M | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bristol-Myers Squibb Company Ce (CELG-RI) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 0.32%, while retail and public investors account for the remaining 99.62%.
The largest institutional shareholder of Bristol-Myers Squibb Company Ce is TORONTO DOMINION BANK, holding approximately 807,847 shares — equal to 3.98% of outstanding shares — as of September 30, 2025.
A total of 21 institutional investors currently hold CELG-RI stock, with a combined institutional value of approximately $40,486 as of the most recent 13F filing period.
Frequently asked questions
CELG-RI ownershipBristol-Myers Squibb Company Ce (CELG-RI) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is TORONTO DOMINION BANK with a 3.98% stake. Company insiders hold 0.32%. Data sourced from SEC Form 13F as of September 30, 2025.